MMTV superantigens coerce an unconventional topology between the TCR and MHC class II

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1896-1906

  Fortin, Jean Simon ^a,b   Genève, Laetitia ^a   Gauthier, Catherine ^a   Shoukry, Naglaa H ^c   Azar, Georges A ^a,e   Younes, Souheil ^c   Yassine Diab, Bader ^c   Sékaly, Rafick Pierre ^d   Fremont, Daved H ^b   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Vaccine and Gene Therapy Institute of Florida   (United States)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MOUSE MAMMARY TUMOR VIRUS SUPERANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 3; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; COVALENT BOND; HUMAN; HUMAN CELL; HYBRIDOMA; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN STRUCTURE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, VIRAL; BINDING SITES; HEK293 CELLS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MAMMARY TUMOR VIRUS, MOUSE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 84896735813     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203130     Document Type: Article

References (99)

1. Fraser, J. D., and T. Proft. 2008. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225: 226-243.
2. Acha-Orbea, H., A. N. Shakhov, and D. Finke. 2007. Immune response to MMTV infection. Front. Biosci. 12: 1594-1609.
3. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9: 101-128.
4. Sundberg, E. J., L. Deng, and R. A. Mariuzza. 2007. TCR recognition of peptide/MHC class II complexes and superantigens. Semin. Immunol. 19: 262-271.
5. Bueno, C., G. Criado, J. K. McCormick, and J. Madrenas. 2007. T cell signalling induced by bacterial superantigens. Chem. Immunol. Allergy 93: 161-180.
6. Li, H., A. Llera, E. L. Malchiodi, and R. A. Mariuzza. 1999. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 17: 435-466.
7. Korman, A. J., P. Bourgarel, T. Meo, and G. E. Rieckhof. 1992. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 11: 1901-1905.
8. McMahon, C. W., L. Y. Bogatzki, and A. M. Pullen. 1997. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells. Virology 228: 161-170.
9. Winslow, G. M., P. Marrack, and J. W. Kappler. 1994. Processing and major histocompatibility complex binding of the MTV7 superantigen. Immunity 1: 23-33.
10. Delcourt, M., J. Thibodeau, F. Denis, and R. P. Sekaly. 1997. Paracrine transfer of mouse mammary tumor virus superantigen. J. Exp. Med. 185: 471-480.
11. Grigg, M. E., C. W. McMahon, S. Morkowski, A. Y. Rudensky, and A. M. Pullen. 1998. Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway. J. Virol. 72: 2577-2588.
12. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13: 459-486.
13. Pullen, A. M., J. Bill, R. T. Kubo, P. Marrack, and J. W. Kappler. 1991. Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor Vβ. J. Exp. Med. 173: 1183-1192.
14. Pullen, A. M., T. Wade, P. Marrack, and J.W. Kappler. 1990. Identification of the region of T cell receptor β chain that interacts with the self-superantigen MIs-1a. Cell 61: 1365-1374.
15. Cazenave, P. A., P. N. Marche, E. Jouvin-Marche, D. Voegtlé, F. Bonhomme, A. Bandeira, and A. Coutinho. 1990. Vβ17 gene polymorphism in wild-derived mouse strains: two amino acid substitutions in the Vβ17 region greatly alter T cell receptor specificity. Cell 63: 717-728.
16. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9: 745-772.
17. MacNeil, D., E. Fraga, and B. Singh. 1992. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor β chain. Eur. J. Immunol. 22: 937-941.
18. Torres, B. A., N. D. Griggs, and H. M. Johnson. 1993. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens. Nature 364: 152-154.
19. Pullen, A. M., and L. Y. Bogatzki. 1996. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics. J. Immunol. 156: 1865-1872.
20. Azar, G. A., R. P. Sékaly, and J. Thibodeau. 2005. A defective viral superantigenpresenting phenotype in HLA-DR transfectants is corrected by CIITA. J. Immunol. 174: 7548-7557.
21. Mottershead, D. G., P. N. Hsu, R. G. Urban, J. L. Strominger, and B. T. Huber. 1995. Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity 2: 149-154.
22. Hsu, P. N., P. Wolf Bryant, N. Sutkowski, B. McLellan, H. L. Ploegh, and B. T. Huber. 2001. Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis. J. Immunol. 166: 3309-3314.
23. Faubert, A., A. Samaan, and J. Thibodeau. 2002. Functional analysis of tryptophans α62 and β120 on HLA-DM. J. Biol. Chem. 277: 2750-2755.
24. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
25. Kozono, H., J. White, J. Clements, P. Marrack, and J. W. Kappler. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369: 151-154.
26. Winslow, G. M., M. T. Scherer, J. W. Kappler, and P. Marrack. 1992. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a). Cell 71: 719-730.
27. Fu, X. T., and R. W. Karr. 1994. HLA-DR α chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes. Hum. Immunol. 39: 253-260.
28. Radka, S. F., C. E. Machamer, and P. Cresswell. 1984. Analysis of monoclonal antibodies reactive with human class II β chains by two-dimensional electrophoresis and Western blotting. Hum. Immunol. 10: 177-186.
29. Wraight, C. J., P. van Endert, P. Möller, J. Lipp, N. R. Ling, I. C. MacLennan, N. Koch, and G. Moldenhauer. 1990. Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol. Chem. 265: 5787-5792.
30. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1: 595-606.
31. Mahana, W., R. al-Daccak, C. Léveillé, J. P. Valet, J. Hébert, M. Ouellette, and W. Mourad. 1995. A natural mutation of the amino acid residue at position 60 destroys staphylococcal enterotoxin A murine T-cell mitogenicity. Infect. Immun. 63: 2826-2832.
32. Herman, A., G. Croteau, R. P. Sekaly, J. Kappler, and P. Marrack. 1990. HLADR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J. Exp. Med. 172: 709-717.
33. Hewitt, C. R. A., J. R. Lamb, J. Hayball, M. Hill, M. J. Owen, and R. E. O'Hehir. 1992. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J. Exp. Med. 175: 1493-1499.
34. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
35. Sette, A., S. Ceman, R. T. Kubo, K. Sakaguchi, E. Appella, D. F. Hunt, T. A. Davis, H. Michel, J. Shabanowitz, R. Rudersdorf, et al. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258: 1801-1804.
36. Lavoie, P. M., J. Thibodeau, I. Cloutier, R. Busch, and R. P. Sékaly. 1997. Selective binding of bacterial toxins to major histocompatibility complex class IIexpressing cells is controlled by invariant chain and HLA-DM. Proc. Natl. Acad. Sci. USA 94: 6892-6897.
37. + T cells in H-2Ma0/0 mice. Immunity 7: 187-195.
38. Golovkina, T., Y. Agafonova, D. Kazansky, and A. Chervonsky. 2001. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens. J. Immunol. 166: 2244-2250.
39. Hogan, R. J., J. VanBeek, D. R. Broussard, S. L. Surman, and D. L. Woodland. 2001. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells. J. Immunol. 166: 6514-6522.
40. Schulze, E. D., and K. W. Wucherpfennig. 2012. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 24: 105-111.
41. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343: 71-74.
42. Ignatowicz, L., G. Winslow, J. Bill, J. Kappler, and P. Marrack. 1995. Cell surface expression of class II MHC proteins bound by a single peptide. J. Immunol. 154: 3852-3862.
43. Labrecque, N., H. Mcgrath, M. Subramanyam, B. T. Huber, and R. P. Sékaly. 1993. Human T cells respond to mouse mammary tumor virus-encoded superantigen: Vβ restriction and conserved evolutionary features. J. Exp. Med. 177: 1735-1743.
44. Subramanyam, M., B. McLellan, N. Labrecque, R. P. Sekaly, and B. T. Huber. 1993. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J. Immunol. 151: 2538-2545.
45. Riberdy, J. M., J. R. Newcomb, M. J. Surman, J. A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360: 474-477.
46. Gorga, J. C., P. J. Knudsen, J. A. Foran, J. L. Strominger, and S. J. Burakoff. 1986. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. Cell. Immunol. 103: 160-173.
47. + T cells. J. Exp. Med. 176: 275-280.
48. Sundberg, E., and T. S. Jardetzky. 1999. Structural basis for HLA-DQ binding by the streptococcal superantigen SSA. Nat. Struct. Biol. 6: 123-129.
49. Vogt, A. B., L. J. Stern, C. Amshoff, B. Dobberstein, G. J. Hämmerling, and H. Kropshofer. 1995. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155: 4757-4765.
50. Günther, S., A. Schlundt, J. Sticht, Y. Roske, U. Heinemann, K.-H. Wiesmüller, G. Jung, K. Falk, O. Rötzschke, and C. Freund. 2010. Bidirectional binding of invariant chain peptides to an MHC class II molecule. Proc. Natl. Acad. Sci. USA 107: 22219-22224.
51. Thibodeau, J., N. Labrecque, F. Denis, B. T. Huber, and R. P. Sékaly. 1994. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules. J. Exp. Med. 179: 1029-1034.
52. Hennecke, J., A. Carfi, and D. C. Wiley. 2000. Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19: 5611-5624.
53. O'Sullivan, D., T. Arrhenius, J. Sidney, M. F. Del Guercio, M. Albertson, M. Wall, C. Oseroff, S. Southwood, S. M. Colón, et al. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol. 147: 2663-2665.
54. De Magistris, M. T., J. Alexander, M. Coggeshall, A. Altman, F. C. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68: 625-634.
55. b molecule can stimulate and stain antigen-specific T cells. Mol. Immunol. 39: 861-870.
56. Thibodeau, J., M. Dohlsten, I. Cloutier, P. M. Lavoie, P. Bjork, F. Michel, C. Léveillé, W. Mourad, T. Kalland, and R. P. Sékaly. 1997. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain. J. Immunol. 158: 3698-3704.
57. Labrecque, N., J. Thibodeau, and R. P. Sékaly. 1993. Interactions between staphylococcal superantigens and MHC class II molecules. Semin. Immunol. 5: 23-32.
58. Natarajan, S. K., L. J. Stern, and S. Sadegh-Nasseri. 1999. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. J. Immunol. 162: 3463-3470.
59. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo, O. Schwartz, and P. Benaroch. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98: 12144-12149.
60. Blackman, M. A., and D. L. Woodland. 1996. Role of the T cell receptor alphachain in superantigen recognition. Immunol. Res. 15: 98-113.
61. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. I. Chi, C. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711-718.
62. Crooks, G. E., G. Hon, J. Chandonia, and S. E. Brenner. 2004. WebLogo : a sequence logo generator. Genome Res. 14: 1188-1190.
63. Kappler, J. W., A. Herman, J. Clements, and P. Marrack. 1992. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med. 175: 387-396.
64. Li, H., A. Llera, D. Tsuchiya, L. Leder, X. Ysern, P. M. Schlievert, K. Karjalainen, and R. A. Mariuzza. 1998. Three-dimensional structure of the complex between a T cell receptor β chain and the superantigen staphylococcal enterotoxin B. Immunity 9: 807-816.
65. Wirth, S., A. Vessaz, C. Krummenacher, F. Baribaud, H. Acha-Orbea, and H. Diggelmann. 2002. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule. J. Virol. 76: 11172-11175.
66. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378: 457-462.
67. Zhu, Y., A. Y. Rudensky, A. L. Corper, L. Teyton, and I. A. Wilson. 2003. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. J. Mol. Biol. 326: 1157-1174.
68. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7: 387-399.
69. Wen, R., D. R. Broussard, S. Surman, T. L. Hogg, M. A. Blackman, and D. L. Woodland. 1997. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Eur. J. Immunol. 27: 772-781.
70. Suri, A., S. B. Lovitch, and E. R. Unanue. 2006. The wide diversity and complexity of peptides bound to class II MHC molecules. Curr. Opin. Immunol. 18: 70-77.
71. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84: 531-541.
72. Painter, C. A., M. P. Negroni, K. A. Kellersberger, Z. Zavala-Ruiz, J. E. Evans, and L. J. Stern. 2011. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Proc. Natl. Acad. Sci. USA 108: 19329-19334.
73. Chervonsky, A. V., R. M. Medzhitov, L. K. Denzin, A. K. Barlow, A. Y. Rudensky, and C. A. Janeway, Jr. 1998. Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. Proc. Natl. Acad. Sci. USA 95: 10094-10099.
74. + T cells in mice lacking invariant chain. J. Immunol. 156: 2133-2142.
75. Tobita, T., M. Oda, H. Morii, M. Kuroda, A. Yoshino, T. Azuma, and H. Kozono. 2003. A role for the P1 anchor residue in the thermal stability of MHC class II molecule I-Ab. Immunol. Lett. 85: 47-52.
76. Saline, M., K. E. J. Rödström, G. Fischer, V. Y. Orekhov, B. G. Karlsson, and K. Lindkvist-Petersson. 2010. The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation. Nat. Commun. 1: 119.
77. Wang, L., Y. Zhao, Z. Li, Y. Guo, L. L. Jones, D. M. Kranz, W. Mourad, and H. Li. 2007. Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC. Nat. Struct. Mol. Biol. 14: 169-171.
78. Blackman, M. A., H. G. Burgert, D. L. Woodland, E. Palmer, J. W. Kappler, and P. Marrack. 1990. A role for clonal inactivation in T cell tolerance to Mls-1a. Nature 345: 540-542.
79. Woodland, D. L., H. P. Smith, S. Surman, P. Le, R. Wen, and M. A. Blackman. 1993. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J. Exp. Med. 177: 433-442.
80. Pircher, H., T. W. Mak, R. Lang, W. Ballhausen, E. Rüedi, H. Hengartner, R. M. Zinkernagel, and K. Bürki. 1989. T cell tolerance to Mlsa encoded antigens in T cell receptor Vβ8.1 chain transgenic mice. EMBO J. 8: 719-727.
81. Yui, K., S. Komori, M. Katsumata, R. M. Siegel, and M. I. Greene. 1990. Selfreactive T cells can escape clonal deletion in T-cell receptor Vβ8.1 transgenic mice. Proc. Natl. Acad. Sci. USA 87: 7135-7139.
82. Vacchio, M. S., O. Kanagawa, K. Tomonari, and R. J. Hodes. 1992. Influence of T cell receptor Vα expression on Mlsa superantigen-specific T cell responses. J. Exp. Med. 175: 1405-1408.
83. Smith, H. P., P. Le, D. L. Woodland, and M. A. Blackman. 1992. T cell receptor a-chain influences reactivity to Mls-1 in Vβ8.1 transgenic mice. J. Immunol. 149: 887-896.
84. Aude-Garcia, C., A. Attinger, D. Housset, H. R. MacDonald, H. Acha-Orbea, P. N. Marche, and E. Jouvin-Marche. 2000. Pairing of Vβ6 with certain Vα2 family members prevents T cell deletion by Mtv-7 superantigen. Mol. Immunol. 37: 1005-1012.
85. Kang, J., C. A. Chambers, J. Pawling, and C. Scott. 1994. Conserved amino acid residues in the complementarity-determining region 1 of the TCR β-chain are involved in the recognition of conventional Ag and Mls-1 superantigen. J. Immunol. 152: 5305-5317.
86. Marrack, P., G. M. Winslow, Y. Choi, M. Scherer, A. Pullen, J. White, and J. W. Kappler. 1993. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions. Immunol. Rev. 131: 79-92.
87. Nguyen, P., D. L. Woodland, and M. A. Blackman. 1996. MHC bias of Mls-1 recognition is not influenced by thymic positive selection. Cell. Immunol. 167: 224-229.
88. Andersen, P. S., P. M. Lavoie, R. P. Sékaly, H. Churchill, D. M. Kranz, P. M. Schlievert, K. Karjalainen, and R. A. Mariuzza. 1999. Role of the T cell receptor α chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity 10: 473-483.
89. Ciurli, C., D. N. Posnett, R. P. Sékaly, and F. Denis. 1998. Highly biased CDR3 usage in restricted sets of β chain variable regions during viral superantigen 9 response. J. Exp. Med. 187: 253-258.
90. + versus CD8+ cells. J. Exp. Med. 174: 989-1000.
91. + T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition. J. Immunol. 155: 4171-4178.
92. Kilgannon, P., Z. Novak, A. Fotedar, and B. Singh. 2010. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire. Mol. Immunol. 47: 1154-1160.
93. Stadinski, B. D., P. Trenh, R. L. Smith, B. Bautista, P. G. Huseby, G. Li, L. J. Stern, and E. S. Huseby. 2011. A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands. Immunity 35: 694-704.
94. Deng, L., R. J. Langley, Q. Wang, S. L. Topalian, and R. A. Mariuzza. 2012. Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3. Proc. Natl. Acad. Sci. USA 109: 14960-14965.
95. Mehindate, K., J. Thibodeau, M. Dohlsten, T. Kalland, R. P. Sékaly, and W. Mourad. 1995. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J. Exp. Med. 182: 1573-1577.
96. Petersson, K., M. Thunnissen, G. Forsberg, and B. Walse. 2002. Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules. Structure 10: 1619-1626.
97. Nur-ur Rahman, A. K., D. A. Bonsor, C. A. Herfst, F. Pollard, M. Peirce, A. W. Wyatt, K. J. Kasper, J. Madrenas, E. J. Sundberg, and J. K. McCormick. 2011. The T cell receptor β-chain second complementarity determining region loop (CDR2β governs T cell activation and Vβ specificity by bacterial superantigens. J. Biol. Chem. 286: 4871-4881.
98. Woodland, D. L., R. Wen, and M. A. Blackman. 1997. Why do superantigens care about peptides? Immunol. Today 18: 18-22.
99. Proft, T., and J. Fraser. 1998. Superantigens: just like peptides only different. J. Exp. Med. 187: 819-821.